Table 5.
Clinical Outcome of diabetes subjects based on MAGE levels during in-hospital and 30-day follow-up
MAGE (mmol/L) | <2.84 | 2.84-3.96 | >3.96 | P | |
---|---|---|---|---|---|
Subject number (n) |
73 |
24 |
24 |
25 |
NA |
Composite MACE |
18 (24.7) |
2 (8.3) |
6 (25) |
10 (40) |
0.038 |
Non-IRA revascularization | 27 (37) | 4 (15) | 10 (21) | 13 (32) | 0.032 |
Data given as n (%).
MAGE, the mean amplitude of glycemic excursions; MACE, major adverse cardiac events; TVR, target vessel revascularization; IRA, infarct related arteries.